Valproic acid hepatic fatalities. III. U.S. experience since 1986

Neurology

Volumn 46, Issue 2, 1996, Pages 465-469

  Bryant III, Alton E ^a   Dreifuss, Fritz E ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VALPROIC ACID;

ADOLESCENT; ADULT; AGE; ANOREXIA; ARTICLE; BLEEDING; CHILD; DEVELOPMENTAL DISORDER; EDEMA; EPILEPSY; FATALITY; FEMALE; HUMAN; JAUNDICE; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED STATES; VOMITING;

EID: 0029925182     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.2.465     Document Type: Article

References (23)

1. Physician's desk reference, 47th ed. Oradell, NJ: Medical Economics, 1993.
2. Pellock JM. Rational use of valproate in adults and children. In:Levy RH, Penry JK, eds. Idiosyncratic reactions to valproate. New York: Raven, 1991:155-161.
3. Penry JK. Overview: significance of valproate. In:Levy RH, Penry JK, eds. Idiosyncratic reactions to valproate. New York: Raven, 1991:1-2.
4. Smythe MA, Umstead GS. Phenytoin hepatotoxicity: a review of the literature. Ann Pharmacother 1989;23:13-18.
5. Horowitz S, Patwardhan R, Marcus E. Hepatotoxic reactions associated with carbamazepine therapy. Epilepsia 1988;29: 149-154.
6. Roberts EA, Spielberg SP, Goldbach M. Phenobarbital hepatotoxicity in an 8-month-old infant. J Hepatol 1990;10:235-239.
7. Willmore LJ. Clinical manifestations of valproate hepatotoxicity. In:Levy RH, Penry JK, eds. Idiosyncratic reactions to valproate. New York: Raven, 1991:3-6.
8. Schulz H. Inhibition of fatty acid oxidation and mitochondrial metabolism of valproic acid in vitro. In:Levy RH, Penry JK, eds. Idiosyncratic reactions to valproate. New York: Raven, 1991:47-52.
9. Kesterson JW, Garnneman GR, Machinist JM. The hepatotoxicity of valproic acid and its metabolites in rats. I: Toxicologic, biochemical, and histopathologic studies. Hepatology 1984; 4:1143-1152.
10. Baillie TA, Levy R. Metabolic fate of valproic acid in humans. In:Levy RH, Penry JK, eds. Idiosyncratic reactions to valproate. New York: Raven, 1991:19-24.
11. Dreifuss FE, Langer DH. Hepatic considerations in the use of antiepileptic drugs. Epilepsia 1987;28(suppl. 2):S23-S29.
12. Dreifuss FE. Hepatic toxicity of valproate. In:Levy RH, Penry JK, eds. Idiosyncratic reactions to valproate. New York: Raven, 1991:9-12.
13. Levy RH, Lin JMH, Acheampong AA, Russell RG. Dose effect of L-carnitine on delta-4-VPA-associated hepatotoxicity. In: Levy RH, Penry JK, eds. Idiosyncratic reactions to valproate. New York: Raven, 1991:25-29.
14. Harris RA, Swartzentruber M, Becker C-M, McCune SA, Hu H, Popov K. Metabolic effects of sequestration of hepatic mitochondrial coenzyme A by valproate and other carboxylic acids. In:Levy RH, Penry JK, eds. Idiosyncratic reactions to valproate. New York: Raven, 1991:97-104.
15. Pippenger CE, Meng X, Rothner AD, Cruise RP, Erenberg G, Solano R. Free radical scavenging enzyme activity profiles in risk assessment of idiosyncratic drug reactions: probable mechanism for valproate-induced acute pancreatitis and hepatotoxicity. In:Levy RH, Penry JK, eds. Idiosyncratic reactions to valproate. New York: Raven, 1991:75-88.
16. Dreifuss FE, Santilli N, Langer DH, Sweeney KP, Moline KA, Menander KB. Valproic acid hepatic fatalities: a retrospective review. Neurology 1987;37:379-385.
17. Dreifuss FE, Langer DH, Moline KA, Maxwell JE. Valproic acid hepatic fatalities. II. US experience since 1984. Neurology 1989;39:201-207.
18. König St A, Siemes H, Blaker F, et al. Severe hepatotoxicity during valproate therapy: an update and report of eight new fatalities. Epilepsia 1994;35:1005-1015.
19. Granneman GR, Wang S-I, Kesterson JW, Machinist JM. The hepatotoxicity of valproic acid and its metabolites in rats. II. Intermediary and valproic acid metabolism. Hepatology 1984; 4:1153-1158.
20. Chabrol B, Mancini J, Chretien D, Rustin P, Munnich A, Pinsard N. Valproate-induced hepatic failure in a case of cytochrome c oxidase deficiency. Eur J Pediatr 1994;153:133-135.
21. Lenn NJ, Ellis WG, Washburn ER, et al. Fatal hepatocerebral syndrome in siblings discordant for exposure to valproate. Epilepsia 1990;31:578-583.
22. Bicknese AR, May W, Hickey WF. Early childhood hepatocerebral degeneration misdiagnosed as valproate hepatotoxicity. Ann Neurol 1992;32:767-775.
23. Appleton RE, Farrell K, Applegarth DA. The high incidence of valproate hepatotoxicity in infants may relate to familial metabolic defects. Can J Neurol Sci 1990;17:145-148.